login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TRISALUS LIFE SCIENCES INC (TLSI) Stock News
USA
- NASDAQ:TLSI -
US89680M1018
-
Common Stock
4.39
USD
0 (0%)
Last: 11/7/2025, 8:21:49 PM
4.39
USD
0 (0%)
After Hours:
11/7/2025, 8:21:49 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TLSI Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Zacks Investment Research
- Mentions:
ICUI
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
2 days ago - By: Zacks Investment Research
- Mentions:
BTMD
biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates
9 days ago - By: TriSalus Life Sciences
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
2 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
8 months ago - By: Benzinga
Examining the Future: TriSalus Life Sciences's Earnings Outlook
3 months ago - By: Zacks Investment Research
- Mentions:
MDT
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance
3 months ago - By: Zacks Investment Research
- Mentions:
MYO
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
3 months ago - By: Benzinga
- Mentions:
BKV
IMCC
VALN
PRTS
...
Earnings Scheduled For August 12, 2025
3 months ago - By: Zacks Investment Research
- Mentions:
ZBH
Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates
3 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
3 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
4 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
5 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
5 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
5 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
6 months ago - By: Zacks Investment Research
- Mentions:
CGC
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
6 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
6 months ago - By: Zacks Investment Research
- Mentions:
OGI
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
6 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
6 months ago - By: Zacks Investment Research
- Mentions:
OGI
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
6 months ago - By: Zacks Investment Research
TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates
6 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
8 months ago - By: Stocktwits
- Mentions:
DWX
IMFL
TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic
8 months ago - By: Zacks Investment Research
- Mentions:
ABT
TriSalus Life Sciences, Inc. (TLSI) Reports Q4 Loss, Tops Revenue Estimates
8 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
8 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
8 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
9 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces Key Appointments to Board of Directors
9 months ago - By: TriSalus Life Sciences
TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
Please enable JavaScript to continue using this application.